Wednesday, 29 March 2017
While IDMP is delayed again, there is a global trend in regulations that demand greater sharing of SPOR data, so companies cannot sit back and wait. To prepare for IDMP, ICSR E2B(R3), the Falsified Medicines Directive, and more, companies are driving to better master their substance, product, organization and referential data.
This webcast outlines different data management strategies and the role for regulatory information management. IDMP experts from Deloitte and Veeva will draw from projects with multiple Top 50 pharmas to identify the foundational elements of good data and associated process implications.